A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement

Trial ID or NCT#

NCT02675114

Status

recruiting iconRECRUITING

Purpose

To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement (AVR).

Investigator(s)

D. Craig Miller
Alan C. Yeung, MD
Michael Fischbein, MD
William Fearon, MD
David Liang, MD
Rajesh Dash, MD
SEND MESSAGE

View on ClinicalTrials.gov